NumFin

Fisher & Paykel Healthcare Corporation Limited

Sümbol: FPH.AX

ASX

23.66

AUD

Turuhind täna

  • 61.8116

    P/E suhe

  • 3.7087

    PEG suhe

  • 13.82B

    MRK Cap

  • 0.01%

    DIV tootlus

Fisher & Paykel Healthcare Corporation Limited (FPH-AX) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Fisher & Paykel Healthcare Corporation Limited (FPH.AX) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Fisher & Paykel Healthcare Corporation Limited fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

balance-sheet.row.cash-and-short-term-investments

0113.3268.5347.2
140.3
135.1
142.1
75.5
28.5
13.6
10.4
7.7
6.3
6.1
6.9
5.5
5.3
7.7
28.6
37.1
47.6
48.3
73.3
102.2

balance-sheet.row.short-term-investments

00.5185.3257.7
75.3
88.8
112.1
19.4
11.5
23.8
33.1
28.4
21
14.9
21.4
6.3
2.9
0
12
14
17
35
0
0

balance-sheet.row.net-receivables

0237.9169.2210.5
216.3
152.9
138.9
120.7
120.3
107.4
93.4
81.6
77.1
79.6
71.4
81
60.3
58.5
55.4
54.6
49.1
59
41.8
34.1

balance-sheet.row.inventory

0342.4332.4248.8
141.9
130.7
117.9
123.7
109.2
96.1
94.5
89.1
84.4
80.1
71.8
69.9
50.8
46.7
36.2
30.9
24.1
21.9
19.2
18.3

balance-sheet.row.other-current-assets

031.152.239.4
4
18.4
0
1.9
1.7
1.8
1.3
1.1
0.4
0.3
1.8
7.2
8.6
5.3
4.5
0.5
0.3
4.6
6.3
8.6

balance-sheet.row.total-current-assets

0724.6822.4846
502.4
437.1
399
319.9
257.9
243.3
235
215.2
195
186.5
180.1
172.7
129.6
118.2
125.3
127.7
122.5
133.8
140.6
163.1

balance-sheet.row.property-plant-equipment-net

01074.7887.2811.1
712.2
577.4
448
389.6
351.6
367.4
349.8
346.7
311.6
254.3
233.3
204.6
186.5
141.9
128.3
82.9
71.5
71.4
64.9
58.9

balance-sheet.row.goodwill

0000
0
0
0
0
0
1.4
1.4
1.4
1
1
1
1
1
0.6
1
1.4
1.8
2.2
0
3

balance-sheet.row.intangible-assets

080.180.473.6
71.6
59
47.4
40.8
32.3
21
9
7.2
5.4
5.4
4.9
4.5
4.3
2.2
2.3
2.4
4
3.9
2.6
0

balance-sheet.row.goodwill-and-intangible-assets

080.180.473.6
71.6
59
47.4
40.8
32.3
22.4
10.4
8.6
6.4
5.4
4.9
4.5
4.3
2.9
3.3
3.8
4
3.9
2.6
3

balance-sheet.row.long-term-investments

093.584.2102.6
15.9
47.6
37.1
24.4
23.5
13.1
17.2
27.9
37.4
44.9
34.2
11
1.5
0
0
2.8
11.4
0
-3.1
0

balance-sheet.row.tax-assets

090.477.474.8
87.9
37.3
32.6
30.1
26.8
19.9
14.7
11.6
9.7
8.8
11
16.8
8.7
10.3
10.3
13.2
13.7
7.8
3.1
0

balance-sheet.row.other-non-current-assets

0000
0
0
0
0
0
3.6
3.3
8.6
11.9
17.7
11.6
4.2
1.1
1.4
0.3
0
0.9
11.8
7.3
11.7

balance-sheet.row.total-non-current-assets

01338.71129.21062
887.6
721.4
565.1
484.9
434.2
426.5
395.4
403.4
377
331.1
295
241.1
202.1
156.5
142.1
102.7
101.7
95
74.8
73.5

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

02063.41951.61908
1390
1158.5
964.1
804.7
692.1
669.8
630.3
618.6
572.1
517.6
475.1
413.7
331.7
274.7
267.5
230.3
224.2
228.8
215.3
236.7

balance-sheet.row.account-payables

040.249.852.1
67.1
52.9
30.8
26.9
33.4
27.7
23.2
21.1
22.5
21.1
22.8
23.7
14.7
15.9
19.2
15.1
10.8
8.7
8.4
8.5

balance-sheet.row.short-term-debt

019.915.724.5
89.3
16.6
28.1
19.3
14.7
14.2
45.8
17.1
80.2
17.1
24.5
23.4
65
40.8
23.8
8.1
6.3
3.1
7.5
8.6

balance-sheet.row.tax-payables

06.229.5137.6
34.3
23.4
20.7
13.5
17.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

07458.457.7
21.3
66.2
49.4
36.6
42.3
51.3
63.6
117.4
34.5
81.9
59.6
97.5
21.1
0
0
0
1.9
0
1.5
1.7

Deferred Revenue Non Current

042.500
0
0
0
0
0
0.3
0.7
2.9
3.1
3
2.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0204.9186.4178.9
133.4
84.1
88.2
73.7
69.6
7.5
4.7
24.5
21.6
3.9
4.1
10
2.8
11.4
8.7
7.3
10.2
20.1
11.2
4.8

balance-sheet.row.total-non-current-liabilities

0151114.3116.4
122.6
104.7
80.2
65
68.2
81.5
95.4
155.3
73.3
120.1
84.1
115.6
25.6
1
1.1
0.9
2.5
1.2
1.7
21.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

042.522.526.7
21.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0422.2395.8509.5
446.7
281.8
248
198.5
203.2
198.6
224.2
246.4
223.9
204.3
181.9
209.4
136
81.2
63.5
38.3
32.9
35.9
43.5
84.6

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0287.3246.7231.1
221.8
212.2
189.4
168.1
149.5
145.9
120.4
91.3
63.3
38.7
13
4.1
3.6
193.5
204
192
170.6
172.7
171.9
152.1

balance-sheet.row.retained-earnings

01123.61094.1946.4
664.8
527.3
439.5
358.3
295.9
266.8
224.5
194.9
184
184.7
196.1
187.7
188.7
0
0
0
20.6
20.1
171.9
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0233.2219.8223.1
60.2
139
90
81.3
45.6
58.5
61.2
86
100.8
89.9
84.1
12.5
3.3
-53.9
-0.2
-3.6
-4
-2
-17.4
0

balance-sheet.row.other-total-stockholders-equity

0-3.1-4.7-2
-3.5
-1.7
-2.8
-1.5
-2.2
0
0
0
0
0
0
0
0
53.9
0.2
3.6
4
2
-154.5
0

balance-sheet.row.total-stockholders-equity

01641.11555.91398.5
943.2
876.8
716.1
606.3
488.9
471.2
406.1
372.2
348.2
313.3
293.2
204.3
195.7
193.5
204
192
191.2
192.8
171.9
152.1

balance-sheet.row.total-liabilities-and-stockholders-equity

02063.41951.61908
1390
1158.5
964.1
804.7
692.1
669.8
630.3
618.6
572.1
517.6
475.1
413.7
331.7
274.7
267.5
230.3
224.2
228.8
215.3
236.7

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

01641.11555.91398.5
943.2
876.8
716.1
606.3
488.9
471.2
406.1
372.2
348.2
313.3
293.2
204.3
195.7
193.5
204
192
191.2
192.8
171.9
152.1

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

093.5269.5360.4
91.1
136.4
149.2
43.8
35
36.9
50.4
56.2
58.5
59.8
55.7
17.3
4.3
0
12
14
17
35
-3.1
0

balance-sheet.row.total-debt

0136.596.6108.9
131.9
82.9
77.5
55.9
57
65.5
109.4
134.5
114.7
99
84.1
121
86.1
40.8
23.8
8.1
8.2
3.1
9
10.3

balance-sheet.row.net-debt

023.213.319.4
66.9
36.6
47.5
-0.2
40.1
51.9
98.9
126.8
108.5
92.9
77.2
115.5
80.9
33.1
7.3
-15
-22.4
-10.2
-64.3
-91.9

Rahavoogude aruanne

Fisher & Paykel Healthcare Corporation Limited finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

cash-flows.row.net-income

0234.3349.1482
278.3
200.9
178.9
155
129.5
0
97.1
77.1
64.1
52.5
71.6
62.2
35.3
57.6
70
61.4
54.7
72.9
48.1
9.7

cash-flows.row.depreciation-and-amortization

092.788.978.2
59.1
40
41.9
35.8
31.8
0
28
21.2
17.8
16.2
13.5
14.3
14.1
13.3
9.5
8.1
7.3
8.4
6.1
5.8

cash-flows.row.deferred-income-tax

04.5-6.3-54.3
-23.2
-3.2
0.5
-1.8
-16.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-250.1-216.3-214.7
-145.6
-85
-84.1
-78.7
-90.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-64.8-38.4-58.4
-27.4
-1.2
6.5
-11.3
-16.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-receivables

0-40.548.6-4.7
-62.8
-11.3
-15.4
3.9
-23.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-6.5-81.8-114.1
-10.1
-10.3
9
-12.9
-22.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

0-17.8-5.360.4
45.4
16.7
6.2
1.8
18.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0000
0
3.6
6.7
-4.2
10.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

0206.4123.4342.2
170.2
91.7
89.3
-0.3
2.6
0
-27.4
-28.9
-7.9
-16.5
21.4
-25.2
-11
-70.9
2.9
-3.2
-9.5
-81.4
1.9
-15.5

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-197.8-157.3-169.8
-165.3
-128
-92.8
-57.7
-59.4
-53.6
-31.9
-62
-67.5
-43.3
-48.3
-22.4
-13.5
-28.7
-53.6
-16.8
-9.5
-16.5
-13.2
0

cash-flows.row.acquisitions-net

0000
0
0.1
0.2
0.1
0
0
0
0
0
0
0
0
0
1.1
1.1
0.9
0
0
0
0

cash-flows.row.purchases-of-investments

000-186.3
0
0
-94
0
0
0
0
0
0
0
0
0
0
-7
-22
-55.3
-80.8
-149.1
0
0

cash-flows.row.sales-maturities-of-investments

0187.274.40
14.5
7.2
0
0
0
0
0
0
0
0
0
0
0
18.8
23.9
58.3
98.5
114.5
299.3
0

cash-flows.row.other-investing-activites

0000
0
0
0
0
0
-14.3
0
0.1
0
0.1
0.1
0
0
-1
-1.1
-1
0
0.1
-5.6
0

cash-flows.row.net-cash-used-for-investing-activites

0-10.6-82.9-356.1
-150.8
-120.7
-186.7
-57.6
-59.3
-53.6
-31.9
-62
-67.5
-43.2
-48.2
-22.4
-13.5
-16.7
-51.7
-13.8
8.2
-51
280.5
0

cash-flows.row.debt-repayment

0-9.4-0.1-45.3
-5
-0.6
-20.3
0
-7.3
-50.2
-30.8
-68.6
-16.8
-27.8
-47.2
-8.6
-12.5
0
-68.5
0
0
-15.7
-14.8
0

cash-flows.row.common-stock-issued

02.833.2
2.2
0.3
0.8
0.7
0.8
1.6
27.1
26.1
23.8
23.3
7
0.2
1.1
0.9
1
1.2
2.3
3.8
30.5
0

cash-flows.row.common-stock-repurchased

00.9146.1
0.3
0
0
0
0
5
8.8
86.6
38.2
35.1
17.6
37
-12.3
0
-5.1
-8
-2.2
0
-212
0

cash-flows.row.dividends-paid

0-183.2-208.3-166.7
-141.8
-110
-96.4
-81.9
-61.5
-47.9
-72.1
-71.1
-70.2
-68.7
-68.1
-66.3
-68
-68.5
-62
-58.7
-56.1
-52.8
-79
0

cash-flows.row.other-financing-activites

04.3-14-10.2
-9.7
1.7
41.5
0.7
0.6
5.5
0.3
0.6
0.6
0.6
0.5
0.6
55.8
19.6
84
0
0
10.7
-2.4
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0-184.5-218.4-172.9
-154
-108.6
-74.4
-80.4
-67.4
-91
-66.7
-26.5
-24.6
-37.5
-90.3
-37.1
-35.8
-48
-50.7
-65.5
-56
-54.1
-277.6
0

cash-flows.row.effect-of-forex-changes-on-cash

02.40.2-1
-1.2
0.6
1.9
0.2
-1.2
1
0.2
1
0.7
-0.2
0.1
0.5
-0.6
-0.4
0.1
-0.2
-0.4
-0.7
-0.3
0

cash-flows.row.net-change-in-cash

030-6.224.5
18.7
16.3
-26.1
39.2
17.4
3.2
5.7
-1
2.6
-9.9
-0.9
3.1
-5.6
-8.8
-5.8
-7.4
12
-59.8
70.3
0

cash-flows.row.cash-at-end-of-period

0113.383.389.5
65
46.3
30
56.1
16.9
-0.5
-3.8
-9.4
-8.4
-11
-1.1
-0.2
-3.3
2.3
11
16.8
24.3
12.2
72
0

cash-flows.row.cash-at-beginning-of-period

083.389.565
46.3
30
56.1
16.9
-0.5
-3.8
-9.4
-8.4
-11
-1.1
-0.2
-3.3
2.3
11
16.8
24.3
12.2
72
1.7
0

cash-flows.row.operating-cash-flow

0222.9300.4575
311.3
243.2
233.1
177.4
130.5
144
97.6
69.3
74
52.2
106.5
51.3
38.4
56.3
82.4
66.4
52.5
46
56.1
0

cash-flows.row.capital-expenditure

0-197.8-157.3-169.8
-165.3
-128
-92.8
-57.7
-59.4
-53.6
-31.9
-62
-67.5
-43.3
-48.3
-22.4
-13.5
-28.7
-53.6
-16.8
-9.5
-16.5
-13.2
0

cash-flows.row.free-cash-flow

025.2143.1405.1
146
115.2
140.2
119.7
71.1
90.4
65.8
7.3
6.5
8.9
58.3
28.9
24.9
27.6
28.8
49.6
42.9
29.5
42.9
0

Kasumiaruande rida

Fisher & Paykel Healthcare Corporation Limited tulud muutusid võrreldes eelmise perioodiga NaN%. FPH.AX brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

income-statement-row.row.total-revenue

01486.91521.31791.4
1233.4
1029.3
907.1
796.8
738.7
644
568.6
507.3
466.7
467.7
474.8
485.5
346
349.2
289.5
241.1
214.9
208.4
213.3
192.8

income-statement-row.row.cost-of-revenue

0601.6582.6667.2
414.5
340.4
310.7
278.6
265.2
261.4
258
248.4
241.7
228.4
231.9
212.1
177.8
149.1
121.4
67.2
62.6
67.6
65.8
0

income-statement-row.row.gross-profit

0885.3938.71124.2
819
688.9
596.4
518.2
473.5
382.6
310.6
258.8
225.1
239.3
242.8
273.4
168.2
200.1
168.2
173.9
152.3
140.9
147.4
192.8

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-7.640.232.4
-16.8
3.3
21.4
31.3
2
33.3
59.4
52.8
52.4
39.6
32.8
-23.8
11.9
7.2
34.9
12
10.7
76
-111.6
-50

income-statement-row.row.operating-expenses

0567.4506.8490.4
442.2
388.6
348
325.6
284.8
277.5
255.5
223.9
207.2
203.2
190.3
164.5
138.2
131
108.6
92.4
81.6
75.4
6.1
63.3

income-statement-row.row.cost-and-expenses

01168.91089.41157.6
856.7
729.1
658.7
604.2
550
538.9
513.5
472.3
448.8
431.6
422.2
376.6
315.3
280.1
341.8
159.7
206.8
210.6
139.1
63.3

income-statement-row.row.interest-income

02.42.41.4
2.1
3.2
1.5
0.4
0.1
0.1
0.1
0.2
0.3
0.6
0.7
1.3
0.7
0.8
1.2
1.6
2.4
3.5
1.3
0.2

income-statement-row.row.interest-expense

06.34.54.6
3.8
2.4
3.5
3.5
8.2
11.5
7.8
4.9
0.8
5.5
-3.3
18.6
4.5
2.9
0.8
0.3
0.4
0.5
1.6
2.2

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-1135.126.6
-17.9
-25.4
-1.2
21.3
-12
33.3
59.4
52.8
52.4
39.6
32.8
-23.8
11.9
7.2
34.9
10.1
10.3
45.8
-112
-50

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-7.640.232.4
-16.8
3.3
21.4
31.3
2
33.3
59.4
52.8
52.4
39.6
32.8
-23.8
11.9
7.2
34.9
12
10.7
76
-111.6
-50

income-statement-row.row.total-operating-expenses

0-1135.126.6
-17.9
-25.4
-1.2
21.3
-12
33.3
59.4
52.8
52.4
39.6
32.8
-23.8
11.9
7.2
34.9
10.1
10.3
45.8
-112
-50

income-statement-row.row.interest-expense

06.34.54.6
3.8
2.4
3.5
3.5
8.2
11.5
7.8
4.9
0.8
5.5
-3.3
18.6
4.5
2.9
0.8
0.3
0.4
0.5
1.6
2.2

income-statement-row.row.depreciation-and-amortization

092.788.978.2
59.1
40
41.9
35.8
31.8
0
28
21.2
17.8
16.2
13.5
14.3
14.1
13.3
9.5
8.1
7.3
8.4
6.1
5.8

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0318431.9633.8
376.8
300.2
248.4
192.6
188.7
201.9
55.1
34.9
17.9
36.1
52.6
108.9
30.7
69.1
69.2
81.5
70.6
65.4
75.2
129.6

income-statement-row.row.income-before-tax

0307467660.4
358.9
274.8
247.2
213.9
176.8
158.8
136.7
109.4
92.3
92.8
106.8
85
54.3
87.5
104.4
91.6
80.9
111.2
93.9
16.8

income-statement-row.row.income-tax-expense

072.7117.9178.4
80.6
73.9
68.3
58.9
47.3
45.6
39.6
32.3
28.2
40.3
35.2
22.8
19
29.9
34.5
91.6
80.9
111.2
93.9
16.8

income-statement-row.row.net-income

0250.3376.9524.2
287.3
209.2
190.2
169.2
143.4
113.2
97.1
77.1
64.1
52.5
71.6
62.2
35.3
57.6
70
61.4
54.7
72.9
48.1
9.7
Sarnased aktsiad
Sind võib huvitada ka:
CNVVF
ConvaTec Group Plc.
3.2 USD
PNK
300753.SZ
Jiangsu Apon Medical Technology Co., Ltd..
13.2 CNY
SHZ
BLCO
Bausch + Lomb Corporation.
15.29 USD
NYSE
137310.KS
SD BioSensor, Inc.
10740 KRW
KSC
YPHDF
Ypsomed Holding AG.
362 USD
PNK
INFU
InfuSystem Holdings, Inc..
7.56 USD
AMEX
688289.SS
Sansure Biotech Inc..
20.69 CNY
SHH
7780.T
Menicon Co., Ltd..
1516.5 JPY
JPX
ALC.SW
Alcon Inc..
72.94 CHF
SIX
8086.T
Nipro Corporation.
1256 JPY
JPX
6929.HK
OrbusNeich Medical Group Holdings Limited.
4.42 HKD
HKSE

Korduma kippuv küsimus

Mis on Fisher & Paykel Healthcare Corporation Limited (FPH.AX) koguvara?

Fisher & Paykel Healthcare Corporation Limited (FPH.AX) koguvara on 2063359237.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.601.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 0.051.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.153.

Mis on ettevõtte kogutulu?

Kogutulu on 0.219.

Mis on Fisher & Paykel Healthcare Corporation Limited (FPH.AX) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 250300000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 136465310.000.

Mis on tegevuskulude arv?

Tegevuskulud on 567388691.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.